摘要
目的探讨依那西普治疗强直性脊柱炎的效果。方法选取2015年6月—2017年6月在医院进行治疗的60例强直性脊柱炎患者为研究对象,平均分为为两组,对照组应用柳氮磺吡啶片和甲氨蝶呤片,观察组在对照组的基础上应用依那西普。结果治疗后,两组的BASDAI、BASFI、VAS评分低于治疗前,观察组低于对照组(P<0.05)。结论依那西普治疗强直性脊柱炎的疗效显著。
Objective To investigate the effect of etanercept in the treatment of ankylosing spondylitis. Methods Sixty patients with ankylosing spondylitis who were treated in the hospital from June 2015 to June 2017 were divided into two groups equally. The control group was treated with sulfasalazine tablets and methotrexate tablets. The observation group used etanercept on the basis of the control group. Results After treatment,the scores of BASDAI,BASFI and VAS in the two groups were lower than those before the treatment,and the observation group was lower than the control group(P<0.05). Conclusion Etancept has a significant effect in the treatment of ankylosing spondylitis.
出处
《大医生》
2017年第9期104-105,共2页
Doctor
